Selling Your Veterinary Practice to NVA: A Vet’s 2026 Guide

Key takeaways

• National Veterinary Associates (NVA) is one of the largest veterinary practice consolidators globally, owned by JAB Holdings since 2019 (the privately-held Luxembourg investment vehicle whose other holdings include Krispy Kreme, Panera, and Pret a Manger).
• JAB’s long-term hold philosophy is a notable feature of NVA’s ownership structure — JAB describes itself as a long-term holder rather than a fund with a defined short cycle, per JAB’s own published investment posture.
• NVA’s general approach is to preserve local practice branding post-acquisition, per NVA company materials. Specific brand handling is determined under the definitive purchase agreement on a case-by-case basis.
• NVA’s specific deal structures are negotiated case-by-case and not publicly enumerated. The partnership and joint venture structures available across the broader market may or may not be standard at NVA — that question is best answered through a structured competitive process where multiple buyers compete on full deal terms.
• The most reliable way to know what NVA — or any private equity-backed buyer — would actually pay for your specific practice is to run a structured competitive process. We call ours the Elite Selling System: we hand-select and vet every buyer who gets to bid, the way a doorman with a velvet rope lets in only the right people, then run a private bidding window inside that vetted group. NVA is invited inside that rope on practices that fit their criteria — and when they bid against a curated group of qualified competitors, the number is reliably very different from what they would offer in a direct, single-bidder conversation.

A vet called me a few months back with a familiar story. NVA’s acquisition team had reached out the previous Wednesday.

They’d had a one-hour conversation about a potential acquisition — a discussion that included an indicative number she described as “the kind of number I would have walked into the sunset with 5 years ago.” They’d asked about an exclusivity period to complete diligence.

She wanted to know one thing. Is this number what my practice is actually worth in the market?

The answer to that question is the same answer for almost every major private equity-backed veterinary buyer, but the texture changes for each one based on their ownership structure, their integration philosophy, and what they typically pay. This guide is everything I’d tell a vet about NVA specifically — who they are, who owns them, what they’re paying for practices in 2026, what they target, how they integrate, what to negotiate, and how NVA compares to the other PE-backed buyers who’d compete for your practice in a structured process.

If you’re considering selling to NVA, or if NVA has already called you with an offer in hand, this guide will give you the same picture I’d give a client in person over dinner.

Quick facts on National Veterinary Associates

NVA is one of the largest veterinary practice consolidators globally. The company supports more than 1,500 companion animal practices, equine hospitals, and pet resorts worldwide as of 2025, with the majority of its footprint in North America and substantial operations in the United Kingdom, Australia, and New Zealand.

NVA’s headquarters are in Agoura Hills, California. The company was founded in 1996 as one of the early generation of veterinary consolidators.

It has been through three rounds of private equity ownership, the most recent (and current) being JAB Holdings.

The current ownership matters more than most owners realize. JAB Holdings acquired NVA in 2019 for approximately $5.3 billion from prior PE owner Ares Management. JAB is the privately-held Luxembourg-based investment vehicle of Germany’s Reimann family.

Beyond NVA, JAB’s portfolio includes Krispy Kreme, Panera Bread, Pret a Manger, Caribou Coffee, Peet’s Coffee, Espresso House, and Keurig Dr Pepper. JAB is a long-term holder rather than a typical 3-to-5-year-cycle PE fund — their typical hold period runs 7 or more years.

That longer hold horizon influences how NVA approaches acquisitions, integrations, and the relationships with the selling vets who become NVA medical directors post-close.

In 2021, JAB merged Compassion First Pet Hospitals into NVA, significantly expanding the specialty hospital footprint. NVA today operates a mix of general practice, specialty, and emergency hospitals, with the bulk of the portfolio in general practice.

What NVA actually pays for veterinary practices in 2026

A real example from our work. A practice owner in her mid-40s came to us with an initial direct offer from a private equity-backed buyer in the mid-eight-figure range. Through our competitive process, the winning bid landed several million dollars above the original direct offer — meaningful seven-figure additional value that would have been left on the table with the direct deal.

The competitive process took roughly 10 days from launch to acceptance, with funds in her account within 90 days of the original conversation.

NVA’s typical multiples vary by practice profile. The ranges below come from a combination of public PE/credit research commentary (particularly Octus’s coverage of veterinary roll-ups), Capstone Partners‘ pet sector M&A updates, and the patterns I see across deals where NVA participates as a bidder.

NVA does not publish a standard price sheet for any specific practice profile. Per industry M&A commentary (Octus, Capstone Partners, 2025-2026), competitive outcomes for strong multi-doctor practices in the $2 million-plus revenue range tend to land in the low-teens EBITDA range across the PE-backed buyer pool.

The actual number for any specific practice depends heavily on whether other buyers are at the table and the specific profile of the practice. NVA’s specific offer on any specific deal is negotiated case by case under confidentiality and is not publicly enumerated.

For specialty and emergency hospitals, the broader market generally values these higher than comparable GP practices per industry research, though the exact number is buyer-specific and process-dependent. NVA’s specialty footprint expanded materially after the 2021 Compassion First merger and the 2022-2023 Ethos integration into NVA per public announcements at the time.

For larger multi-location groups ($10 million-plus revenue, $2 million-plus EBITDA), the multiple range typically extends higher than for single-location GP practices, with deal sizes scaling into the eight-figure-plus range. As with the smaller bands, the actual number reflects buyer competition more than any one buyer’s posted preferences.

For practices below the $2 million revenue threshold or single-doctor practices, the buyer pool generally shifts toward regional PE-backed groups, smaller consolidators, and individual buyers. Specific NVA acquisition criteria are not publicly published and may vary by region and market opportunity.

The cash-at-close reality

The headline multiple is rarely what lands in the seller’s bank account. Per industry M&A commentary across the PE-backed buyer pool (Dechert, Holland & Knight, Capstone Partners in 2025-2026), the typical PE-backed offer structure allocates the majority of total deal value to cash at close, with the remainder split among earnout, rollover equity, and occasional seller notes.

NVA’s specific structure on any given deal is negotiated case by case.

Per industry M&A commentary across the PE-backed buyer pool (Dechert LLP, Holland & Knight, 2025-2026), the typical PE-backed offer structure allocates the majority of total deal value to cash at close, with the remainder split among earnout, rollover or partnership equity, and occasional seller notes. The specific allocation in any specific NVA offer is negotiated case by case and is not publicly enumerated.

For sellers considering rollover equity, JAB’s published long-hold investment posture means the holding period before any platform-level liquidity event is typically longer than a 3-to-5-year fund cycle. The exact timing of any future NVA-level transaction is not publicly disclosed and depends on JAB’s broader portfolio decisions.

A note on deal structure types in the current market

Before walking through how NVA’s acquisition team approaches transactions, it’s worth noting a structural shift in the broader veterinary M&A market. Per MB Law Firm’s 2025 commentary on healthcare M&A trends, an increasing number of PE-backed veterinary consolidators are offering partnership or joint venture structures rather than 100 percent acquisitions.

In these structures, the buyer acquires a majority stake in the practice (typically 60 to 80 percent), the seller retains 20 to 40 percent as direct equity in the practice itself, and a contractual put/call mechanism defines the buyout date and formula price for the retained equity. Rarebreed Veterinary Partners, Southern Veterinary Partners, IVC Evidensia, and Encore Vet Group explicitly market partnership or co-ownership models in their company materials.

NVA’s specific deal structures are negotiated case-by-case under confidentiality and not publicly enumerated, so we won’t make claims about NVA’s standard practice on this dimension. What we can say is that the broader market is increasingly offering partnership structures as an alternative to traditional 100 percent buyouts, and sellers evaluating any specific NVA offer should ask whether a partnership structure is available alongside the more traditional structure.

Our PE pricing guide covers the comparison in depth.

How NVA’s acquisition team operates

NVA’s acquisition team operates across multiple sourcing channels including direct outreach to practice owners, participation in structured competitive sale processes run by sell-side advisors, and inbound inquiries from owners who reach out directly. The specific NVA outreach team’s process and criteria are not publicly enumerated by NVA.

Per industry M&A commentary, competitive sale processes across the PE-backed buyer pool consistently produce stronger seller outcomes than direct, single-bidder conversations on the same practice. The PE-backed buyer pool — NVA included — is a consistent participant in well-run structured sale processes.

How NVA integrates the practices it acquires

NVA’s integration philosophy is more operational than identity-changing. Most acquired practices keep their original names and signage indefinitely.

The integration shows up in:

Shared back office. Per NVA company materials, the platform provides centralized HR, accounting, payroll, vendor management, supply purchasing, and IT support. The integration timing and approach are determined case by case under NVA’s regional operating structure.

Centralized marketing. Local marketing initiatives often consolidate into NVA’s regional or national marketing programs. The practice’s website typically remains under its original brand but migrates to NVA’s content management platform.

Continuing education and clinical programs. NVA invests meaningfully in continuing education and clinical programming for the doctors in its network. This is one of the genuine value-adds NVA offers practitioners who join the platform.

Doctor relationships. Most selling owners stay on as medical directors for 3 to 5 years post-close, providing continuity to staff and clients during the integration period. The medical director arrangement preserves clinical autonomy while transferring business decisions to NVA’s regional team.

Local brand preservation. Per NVA company materials, NVA’s general approach is to preserve local practice branding and identity post-acquisition. Specific brand handling varies practice by practice and is best confirmed in writing as part of the definitive purchase agreement.

NVA’s recent activity in 2025-2026

NVA is among the active U.S. veterinary practice consolidators in 2026. Per Capstone Partners‘ April 2026 Pet Sector M&A Update, pet sector M&A activity has accelerated meaningfully in early 2026 versus the same window of 2025, with PE-backed and strategic acquirers active across the market.

NVA’s specific 2025-2026 acquisition activity is not publicly enumerated in real time by NVA. Owners receiving outreach from NVA should evaluate the offer in the context of a competitive process where multiple qualified buyers underwrite the same practice in parallel.

Have an offer from NVA? Get a Free NVA Offer Review — send us the offer and we’ll decompose the terms, identify what’s typically negotiable, and project what your practice would likely clear in a structured competitive process with the broader qualified buyer pool. No upfront cost, no obligation.

How NVA compares to the other major buyers

If you’re considering NVA, you’re probably comparing them implicitly to the other major buyers who’d compete for your practice. Here’s how NVA stacks up across the dimensions that matter.

Versus Mars Veterinary Health (VCA, Banfield, BluePearl). Mars is the strategic exception in the buyer pool — family-owned by Mars, Inc., rather than PE-backed, per Mars company disclosures. Both NVA and Mars participate in competitive processes for qualifying practices, with the specific deal terms and brand handling determined case by case under the definitive purchase agreement.

On Ethos Veterinary Health. Ethos was acquired by NVA in 2022-2023 per public announcements at the time and now operates as part of NVA’s specialty and emergency footprint. Sellers receiving an offer that references Ethos are effectively engaging with NVA’s deal team.

On AmeriVet Veterinary Partners. AmeriVet is among the active 2026 mid-market acquirers per AmeriVet company materials. Both NVA and AmeriVet may compete for qualifying practices in a structured sale process; the specific deal terms and structure proposed by either buyer are determined case by case.

On Mission Pet Health. Mission Pet Health, the post-merger entity formed from SVP and MVP per the July 2025 Mission Pet Health press release, is an active 2026 acquirer with a meaningful Southeast and Sun Belt footprint. Both Mission Pet Health and NVA may compete for qualifying practices in a structured sale process; specific deal terms and cultural fit are best evaluated in context per practice.

Versus the smaller PE-backed groups (Thrive, PetVet, VetCor, Pathway). Each has its own integration philosophy and target profile. Smaller groups sometimes pay more aggressively for practices that fill specific geographic or specialty gaps in their portfolio.

The right way to evaluate which buyer pays most is to put all of them in a competitive process and let them surface their best offers in parallel.

What to negotiate before signing with NVA

Five priorities when negotiating an NVA offer.

Cash at close percentage. PE-backed offers in this market generally lean toward the majority of total deal value as cash at close, but the specific percentage NVA initially proposes varies deal by deal. Push for higher cash percentages.

Every dollar shifted from contingent to cash is guaranteed money instead of conditional. NVA’s negotiating posture on cash vs. headline trade-offs is typically pragmatic when the seller has competitive options.

Earnout structure. Earnouts in PE-backed offers commonly run on multi-year EBITDA targets. Push for shorter duration.

Push for revenue-based metrics where possible (the seller has more control over revenue post-close than over EBITDA, which depends on cost decisions the buyer makes). Insist on protective provisions: no major operational changes without seller consent, working capital floor, prohibition on shifting expenses from other practices in the buyer’s portfolio to the seller’s practice.

Rollover equity terms. If NVA includes rollover in their offer structure (common in PE-backed offers across the sector), negotiate the lockup window down. Lockup windows tend to be tied to the platform’s eventual exit, which on the PE-backed side is often open-ended.

Negotiate a defined liquidity provision tied to specific milestones (5-year mark, sponsor-led recapitalization event, or other defined exits). Get governance rights: minority protection clauses, information rights, anti-dilution provisions.

Non-compete scope. Non-competes in PE-backed offers commonly run several years and cover a defined geographic radius for all veterinary work. That can effectively end your career if you might want to continue practicing somewhere later.

Negotiate: shorter duration (1 to 2 years), tighter radius (5 to 10 miles), or carve out specific specialty or modality if you might continue clinical work post-employment.

Medical director compensation. Per industry M&A commentary on healthcare practice acquisitions, the medical director arrangement typically combines a base salary with a production bonus formula. Specific compensation structures vary by deal and are best negotiated as part of the definitive purchase agreement, with attention to the production bonus formula, floor amounts, and renewal terms.

How to make NVA compete for your practice

NVA is experienced across a very large platform per NVA company materials. Most sellers engaging with any major consolidator are first-time sellers, and the structural information asymmetry between an experienced acquisition team and a first-time seller is one of the reasons sell-side advisors exist.

Across the deals we’ve run, the difference between direct-offer outcomes and competitive-process outcomes on the same practice consistently produces meaningful seven-figure improvements in total deal value across the PE-backed buyer pool. NVA participates in well-run structured sale processes alongside other major buyers.

The most important move for any seller is to evaluate any offer in the context of a competitive process with multiple qualified buyers, rather than signing exclusivity with the first buyer who reaches out — whether that buyer is NVA or any other consolidator.

Got an NVA offer? Evaluate it in a competitive context first.

A common pattern I see with any direct buyer outreach is owners signing a 30-day exclusivity agreement before talking to other qualified buyers. Once exclusivity is signed, the seller cannot solicit other buyers during that window.

The cleaner approach is to evaluate any direct offer in the context of a structured competitive process with multiple qualified bidders. NVA participates in well-run competitive processes when invited.

Sellers preserve optionality by exploring the broader buyer pool before signing exclusivity with any single party.

“I knew that I would get the best value for my practice if I had a professional helping me. And it definitely turned out to be true that having Tom in my corner. I have zero doubt that I would not have gotten the value for my practice if I didn’t have him on my side as well as the ease of it. It was such an easy transition and he made the entire process very simple.”

— Sharon Gorman, Las Vegas, Nevada

Three next steps

If NVA has reached out — or if you’re considering reaching out to them — three concrete moves to make before any commitment.

One: get a defensible normalized EBITDA number documented. Not next month. This quarter.

The number drives every downstream decision in the negotiation. NVA will price against the normalized number, not your P&L number, and having that documented properly before the conversation starts changes the entire dynamic.

Two: get a read on what your specific practice would clear in a competitive process. Not just the indicative number from the initial conversation. The defensible number with the math behind it, based on your practice profile and the curated buyer pool that would actually compete for your specific practice.

Three: send us the NVA offer (or the conversation you’ve had so far) for a free review.

Get a Free NVA Offer Review →

We’ll decompose the offer the way I’d walk through it with a vet over dinner — cash at close, earnout structure, rollover equity terms, non-compete scope, post-sale employment. We’ll tell you what’s typically negotiable and what your practice would likely clear in a structured competitive process with NVA and four to six other qualified buyers all underwriting in parallel.

The review is free and there’s no obligation to engage further. Transitions Elite operates on a success-based engagement model — no upfront fees, no retainer.

We only get paid when a deal closes, and only out of the value our process delivers above what you would have realized in a direct, single-bidder conversation.

---

Frequently asked questions

What is National Veterinary Associates (NVA)?

National Veterinary Associates is one of the largest veterinary practice consolidators globally, supporting more than 1,500 companion animal practices, equine hospitals, and pet resorts worldwide as of 2025. NVA is owned by JAB Holdings, the privately-held Luxembourg-based investment vehicle of Germany’s Reimann family.

JAB acquired NVA in 2019 for approximately $5.3 billion from prior owner Ares Management.

Who owns National Veterinary Associates?

NVA is owned by JAB Holdings, the Luxembourg-based privately-held investment vehicle of the Reimann family. JAB acquired NVA in 2019 from Ares Management for approximately $5.3 billion.

JAB also owns Krispy Kreme, Panera Bread, Pret a Manger, Caribou Coffee, Peet’s Coffee, and Keurig Dr Pepper. The 2021 merger of Compassion First Pet Hospitals into NVA significantly expanded NVA’s specialty hospital footprint.

How much does NVA pay for veterinary practices?

NVA does not publish a standard price sheet. In processes where NVA participates as a bidder, competitive outcomes for strong multi-doctor general practices typically land in the low-teens EBITDA range, with specialty and emergency hospitals generally clearing meaningfully higher.

The headline number for any specific deal varies based on practice profile and competitive pressure. PE-backed offers across the sector typically allocate the majority of total deal value to cash at close, with the rest split among earnout, rollover equity, and occasional seller notes.

How does NVA acquire veterinary practices?

NVA’s acquisition team sources potential acquisitions through industry data, broker and sell-side advisor relationships, and direct outreach. The specific NVA acquisition process and criteria are not publicly enumerated.

As with any major consolidator, sellers benefit from evaluating any direct offer in the context of a structured competitive process with multiple qualified buyers rather than signing exclusivity with a single party before exploring alternatives.

Does NVA keep the practice name after acquisition?

Per NVA company materials, NVA’s general approach is to preserve local practice branding post-acquisition, with integration focused on operational support rather than brand consolidation. The specific brand handling for any acquired practice is determined under the definitive purchase agreement on a case-by-case basis.

What is NVA’s post-sale employment commitment for selling doctors?

Per industry M&A commentary on PE-backed healthcare practice acquisitions, selling owners commonly stay on as medical director for a multi-year post-close period, with compensation typically structured as a base salary plus production bonus. NVA’s specific post-sale employment terms and non-compete scope for any given deal are negotiated case by case under the definitive purchase agreement and are not publicly enumerated.

Is NVA a good buyer for my veterinary practice?

NVA is one of the active veterinary practice consolidators in 2026 per company materials and participates in well-run structured sale processes for qualifying practices. JAB Holdings‘ published long-hold investment posture, NVA’s general approach of local brand preservation, and the platform’s substantial operational support are features sellers commonly evaluate.

As with any major acquirer, NVA is best evaluated head-to-head against a curated group of other qualified buyers in a competitive process where each bidder underwrites the same practice in parallel.

What’s the biggest negotiation point when selling to NVA?

The earnout structure. Earnouts are a common feature of PE-backed offer structures across the sector, typically running multi-year on EBITDA targets.

After acquisition, integration changes can reduce practice-level EBITDA in years 1 and 2. This can cause owners to forfeit a significant portion of the earnout.

Protective provisions in the earnout language — no major operational changes without seller consent, working capital floor, prohibition on shifting expenses to the practice — separate earnouts that pay out from earnouts that wither.

---

Sources

NVA and JAB Holdings company disclosures

1. National Veterinary Associates corporate “About” page, accessed 2025.
2. JAB Holdings — public commentary on NVA acquisition (2019).
3. Compassion First Pet Hospitals — NVA merger announcement (2021).

Industry M&A research and market data

4. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
5. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion — VSOs Under Increasing Pressure.” 2025. octus.com
6. Mordor Intelligence. “Veterinary Medicine Market.” mordorintelligence.com

Veterinary profession data

7. AVMA. “Just released: AVMA data and insights on the veterinary profession.” avma.org

Legal and regulatory analysis

8. Dechert LLP. “Healthcare Investments Flash Alert — Latest Developments.” 2025. dechert.com
9. Holland & Knight. “Q1 Recap on Proposed Legislation Affecting Healthcare Consolidation.” 2026. hklaw.com